» Articles » PMID: 30373165

Future in the Past: Wedd. As a Source of New Natural Compounds with Antiproliferative and Cytotoxic Activity on Multiple Myeloma Cells

Abstract

Multiple myeloma (MM) is the second most common hematologic malignancy and, although the development of novel agents has improved survival of patients, to date, it remains incurable. Thus, newer and more effective therapeutic strategies against this malignancy are necessary. Plant extracts play an important role in anti-tumor drug discovery. For this reason, in the investigation of novel natural anti-MM agents, we evaluated the phytochemical profiles, in vitro antioxidant activity, and effects on MM cells of (AG) Wedd. Total polyphenols (TPC), flavonoids (TFC), and terpenoids (TTeC) contents were different among samples and the richest fractions in polyphenols demonstrated a higher antioxidant activity in in vitro assays. Some fractions showed a dose and time dependent anti-proliferative activity on MM cells. The chloroform fraction (CHCl₃) showed major effects in terms of reduction of cell viability, induction of apoptosis, and cell cycle arrest on MM cells. The apoptosis induction was also confirmed by the activation of caspase-3. Importantly, the CHCl₃ fraction exhibited a negligible effect on the viability of healthy cells. These results encourage further investigations on AG extracts to identify specific bioactive compounds and to define their potential applications in MM.

Citing Articles

Tunisian Artemisia campestris L.: a potential therapeutic agent against myeloma - phytochemical and pharmacological insights.

Limam I, Ghali R, Abdelkarim M, Ouni A, Araoud M, Abdelkarim M Plant Methods. 2024; 20(1):59.

PMID: 38698384 PMC: 11067135. DOI: 10.1186/s13007-024-01185-4.


Enhancement of Yield, Phytochemical Content and Biological Activity of a Leafy Vegetable ( L. var. ) by Using Organic Amendments as an Alternative to Chemical Fertilizer.

Libutti A, Russo D, Lela L, Ponticelli M, Milella L, Rivelli A Plants (Basel). 2023; 12(3).

PMID: 36771653 PMC: 9921681. DOI: 10.3390/plants12030569.


dvances in Wedd. Extract Research: In Vitro Antioxidant Activity, Antiproliferative Effects on Acute Myeloid Leukemia Cells and Bioactive Compound Characterization.

Lamorte D, Faraone I, Laurenzana I, Trino S, Russo D, Rai D Molecules. 2020; 25(21).

PMID: 33105817 PMC: 7660062. DOI: 10.3390/molecules25214890.


L. Extract: Phytochemical Characterization, Antioxidant Activity, and Nanoformulation.

Vassallo A, Armentano M, Miglionico R, Caddeo C, Chirollo C, Gualtieri M Pharmaceutics. 2020; 12(6).

PMID: 32549193 PMC: 7356585. DOI: 10.3390/pharmaceutics12060553.


Phytochemicals of Epling and Their Health-Promoting Bioactivities.

Faraone I, Russo D, Chiummiento L, Fernandez E, Choudhary A, Monne M Foods. 2020; 9(2).

PMID: 32024045 PMC: 7074199. DOI: 10.3390/foods9020144.


References
1.
Park S, Bazer F, Lim W, Song G . The O-methylated isoflavone, formononetin, inhibits human ovarian cancer cell proliferation by sub G0/G1 cell phase arrest through PI3K/AKT and ERK1/2 inactivation. J Cell Biochem. 2018; 119(9):7377-7387. DOI: 10.1002/jcb.27041. View

2.
Fonseca R, Abouzaid S, Bonafede M, Cai Q, Parikh K, Cosler L . Trends in overall survival and costs of multiple myeloma, 2000-2014. Leukemia. 2016; 31(9):1915-1921. PMC: 5596206. DOI: 10.1038/leu.2016.380. View

3.
Siveen K, Uddin S, Mohammad R . Targeting acute myeloid leukemia stem cell signaling by natural products. Mol Cancer. 2017; 16(1):13. PMC: 5282735. DOI: 10.1186/s12943-016-0571-x. View

4.
Palumbo A, Chanan-Khan A, Weisel K, Nooka A, Masszi T, Beksac M . Daratumumab, Bortezomib, and Dexamethasone for Multiple Myeloma. N Engl J Med. 2016; 375(8):754-66. DOI: 10.1056/NEJMoa1606038. View

5.
Gay F, Engelhardt M, Terpos E, Wasch R, Giaccone L, Auner H . From transplant to novel cellular therapies in multiple myeloma: European Myeloma Network guidelines and future perspectives. Haematologica. 2017; 103(2):197-211. PMC: 5792264. DOI: 10.3324/haematol.2017.174573. View